RBM3 and prostate neoplasm: Furthermore, RBM3 was reported to be associated with tumors’ grades as poorly differentiated prostate tumors [14] and high-grade astrocytomas [15] showed higher mRNA and immunoexpression of RBM3 when compared to well-differentiated and low-grade tumors.